Euclidean Capital LLC Alector, Inc. Transaction History
Euclidean Capital LLC
- $906 Million
- Q3 2024
A detailed history of Euclidean Capital LLC transactions in Alector, Inc. stock. As of the latest transaction made, Euclidean Capital LLC holds 1,307,858 shares of ALEC stock, worth $2.25 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
1,307,858
Previous 1,307,858
-0.0%
Holding current value
$2.25 Million
Previous $5.94 Million
2.86%
% of portfolio
0.67%
Previous 0.75%
Shares
2 transactions
Others Institutions Holding ALEC
# of Institutions
168Shares Held
57.8MCall Options Held
146KPut Options Held
90.8K-
Black Rock Inc. New York, NY9.1MShares$15.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.46MShares$9.38 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.63MShares$7.97 Million0.8% of portfolio
-
Morgan Stanley New York, NY4.36MShares$7.49 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.73MShares$4.69 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $142M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...